26 May 2013
Keywords: Ferring, Lysteda, Xanodyne, Zipsor, Licensing
Article | 11 May 2010
Switzerland-based Ferring Pharmaceuticals has entered an agreement that will expand its Women's Health product portfolio with the acquisition of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 May 2010
10 May 2010
24 May 2013
© 2013 thepharmaletter.com